The fetus at the tipping point: modifying the outcome of fetal asphyxia
- PMID: 29774532
- PMCID: PMC6265539
- DOI: 10.1113/JP274949
The fetus at the tipping point: modifying the outcome of fetal asphyxia
Abstract
Brain injury around birth is associated with nearly half of all cases of cerebral palsy. Although brain injury is multifactorial, particularly after preterm birth, acute hypoxia-ischaemia is a major contributor to injury. It is now well established that the severity of injury after hypoxia-ischaemia is determined by a dynamic balance between injurious and protective processes. In addition, mothers who are at risk of premature delivery have high rates of diabetes and antepartum infection/inflammation and are almost universally given treatments such as antenatal glucocorticoids and magnesium sulphate to reduce the risk of death and complications after preterm birth. We review evidence that these common factors affect responses to fetal asphyxia, often in unexpected ways. For example, glucocorticoid exposure dramatically increases delayed cell loss after acute hypoxia-ischaemia, largely through secondary hyperglycaemia. This critical new information is important to understand the effects of clinical treatments of women whose fetuses are at risk of perinatal asphyxia.
Keywords: brain injury; fetus; hypoxia.
© 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society.
Figures
References
-
- Alexandrou G, Skiold B, Karlen J, Tessma MK, Norman M, Aden U & Vanpee M (2010). Early hyperglycemia is a risk factor for death and white matter reduction in preterm infants. Pediatrics 125, e584–e591. - PubMed
-
- Aly H, Elmahdy H, El‐Dib M, Rowisha M, Awny M, El‐Gohary T, Elbatch M, Hamisa M & El‐Mashad AR (2015). Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study. J Perinatol 35, 186–191. - PubMed
-
- Arcangeli T, Thilaganathan B, Hooper R, Khan KS & Bhide A (2012). Neurodevelopmental delay in small babies at term: a systematic review. Ultrasound Obstet Gynecol 40, 267–275. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U54 HD083091/HD/NICHD NIH HHS/United States
- 12/613/Manatu Hauora | Health Research Council of New Zealand (HRC)/International
- 17/601/Manatu Hauora | Health Research Council of New Zealand (HRC)/International
- NF1715-PG/Neurological Foundation of New Zealand/International
- 14,216/Manatu Hauora | Health Research Council of New Zealand (HRC)/International
LinkOut - more resources
Full Text Sources
Other Literature Sources